We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$9.83B
AUM Growth
+$1.07B
Cap. Flow
-$195M
Cap. Flow %
-1.98%
Top 10 Hldgs %
25.87%
Holding
1,420
New
446
Increased
141
Reduced
120
Closed
281

Top Buys

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$63.2M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
GSK icon
GSK
GSK
+$50.8M
4
INFY icon
Infosys
INFY
+$49.3M
5
APH icon
Amphenol
APH
+$46M

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$61.3M
2
NTRS icon
Northern Trust
NTRS
+$59.7M
3
NVDA icon
NVIDIA
NVDA
+$58M
4
CACC icon
Credit Acceptance
CACC
+$53.9M
5
BHP icon
BHP
BHP
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 9.1%
2 Healthcare 3.88%
3 Consumer Staples 2.93%
4 Energy 2.82%
5 Financials 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUD icon
751
CALL
AB InBev
BUD
$156B
$407K ﹤0.01%
6,700
IBIT icon
752
iShares Bitcoin Trust
IBIT
$48.2B
$405K ﹤0.01%
+10,000
New +$312K
BITO icon
753
CALL
ProShares Bitcoin Strategy ETF
BITO
$1.42B
$404K ﹤0.01%
+12,500
New +$315K
INTU icon
754
Intuit
INTU
$83.1B
$402K ﹤0.01%
+618
New +$394K
TLT icon
755
iShares 20+ Year Treasury Bond ETF
TLT
$42.8B
$402K ﹤0.01%
+4,245
New +$402K
MDGL icon
756
CALL
Madrigal Pharmaceuticals
MDGL
$12.7B
$401K ﹤0.01%
+1,500
New +$353K
SEDG icon
757
SolarEdge
SEDG
$2.62B
$400K ﹤0.01%
5,634
-148,814
-96% -$10.7M
RVMDW icon
758
Revolution Medicines Inc Warrant
RVMDW
$105M
$399K ﹤0.01%
+2,185,658
New +$442K
COIN icon
759
Coinbase
COIN
$44.1B
$398K ﹤0.01%
1,500
NPWR.WS icon
760
NET Power Inc Warrants
NPWR.WS
$14.1M
$397K ﹤0.01%
+136,906
New +$268K
INSM icon
761
PUT
Insmed
INSM
$22.7B
$374K ﹤0.01%
+13,800
New +$386K
REPL icon
762
CALL
Replimune Group
REPL
$724M
$370K ﹤0.01%
45,300
-19,800
-30% -$162K
LNW
763
DELISTED
Light & Wonder
LNW
$368K ﹤0.01%
3,607
-4,492
-55% -$406K
AEON.WS
764
DELISTED
AEON Biopharma Inc
AEON.WS
$362K ﹤0.01%
249,999
CYTK icon
765
PUT
Cytokinetics
CYTK
$10.9B
$351K ﹤0.01%
5,000
-192,100
-97% -$14.9M
LKFT
766
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$347K ﹤0.01%
10,768
RBOT.WS
767
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$342K ﹤0.01%
3,913,105
CEG icon
768
Constellation Energy
CEG
$96.4B
$338K ﹤0.01%
+1,830
New +$260K
RGTIW icon
769
Rigetti Computing Warrants
RGTIW
$142M
$338K ﹤0.01%
1,379,733
SCLX icon
770
Scilex Holding
SCLX
$49.4M
$334K ﹤0.01%
6,001
+1,376
+30% +$80.2K
INBX
771
DELISTED
Inhibrx, Inc. Common Stock
INBX
$331K ﹤0.01%
9,458
-5,000
-35% -$182K
IR icon
772
Ingersoll Rand
IR
$33.1B
$326K ﹤0.01%
+3,429
New +$293K
TOIIW
773
The Oncology Institute Warrant
TOIIW
$325K ﹤0.01%
1,624,856
PVH icon
774
PVH
PVH
$3.87B
$323K ﹤0.01%
+2,296
New +$294K
BUD icon
775
AB InBev
BUD
$156B
$321K ﹤0.01%
5,283
+3,296
+166% +$206K

Similar funds

LMR Partners's Q1 2024 Portfolio in Review

As of Q1 2024, LMR Partners held 1,420 positions worth $9.83B, up 12% from $8.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

LMR Partners's Q1 2024 filing shows 446 new, 141 increased, 120 reduced and 281 closed positions. Its largest new stake was GSK: 1,232,283 shares worth $52.8M. The largest sale was Truist Financial, an estimated $61.3M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Consumer Staples.

  • LMR Partners's largest Q1 2024 buy was GSK: 1,232,283 shares worth $52.8M.
  • LMR Partners added most to HDFC Bank in Q1 2024, an estimated $63.2M increase.
  • LMR Partners's biggest Q1 2024 reduction was Credit Acceptance, cutting an estimated $53.9M.
  • LMR Partners fully exited Truist Financial in Q1 2024, selling an estimated $61.3M.
  • LMR Partners's ten largest holdings make up 26% of its $9.83B portfolio in Q1 2024.
  • LMR Partners opened 446 new positions and closed 281 in Q1 2024.
  • LMR Partners's portfolio value rose 12% quarter-over-quarter to $9.83B.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.